TY  - JOUR
AU  - Wagner, Nikolaus B
AU  - Weide, Benjamin
AU  - Gries, Mirko
AU  - Reith, Maike
AU  - Tarnanidis, Kathrin
AU  - Schuermans, Valerie
AU  - Kemper, Charlotte
AU  - Kehrel, Coretta
AU  - Funder, Anne
AU  - Lichtenberger, Ramtin
AU  - Sucker, Antje
AU  - Herpel, Esther
AU  - Holland-Letz, Tim
AU  - Schadendorf, Dirk
AU  - Garbe, Claus
AU  - Umansky, Viktor
AU  - Utikal, Jochen
AU  - Gebhardt, Christoffer
TI  - Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
JO  - Journal for ImmunoTherapy of Cancer
VL  - 7
IS  - 1
SN  - 2051-1426
CY  - London
PB  - BioMed Central
M1  - DKFZ-2019-02953
SP  - 343
PY  - 2019
AB  - Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
LB  - PUB:(DE-HGF)16
C6  - pmid:31806053
DO  - DOI:10.1186/s40425-019-0828-1
UR  - https://inrepo02.dkfz.de/record/148398
ER  -